Skip to main content
logo
Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
35.01
-0.40 (-1.13%)
At close: Jul 31, 2026, 4:00 PM EDT
34.59
-0.42 (-1.21%)
After-hours: Jul 31, 2026, 7:34 PM EDT

Teva Pharmaceutical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
17,31517,25816,54415,84614,92515,878
Revenue Growth
4.13%4.32%4.41%6.17%-6.00%-4.69%
Gross Profit
9,0858,9388,0647,6456,9737,594
Operating Income
1,6032,157-303433-2,1971,715
Net Income
6811,388-1,961-619-2,541438
Earnings Per Share
0.601.21-1.45-0.50-2.200.38
EPS Growth
------

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue from Sale of Goods
14,56614,60514,05012,97912,76613,829
Licensing Arrangements
672678173681212160
Distribution
1,6191,5511,5761,6151,5191,390
Other Segment
457423745570428500
Revenue (Total)
17,31517,25816,54415,84614,92515,878

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,6553,5563,3003,2262,8012,165
Total Debt
16,87417,09418,07920,15321,56123,459
Net Cash (Debt)
-13,219-13,538-14,779-16,927-18,760-21,294
Net Cash Growth
------
Net Cash Per Share
-11.30-11.64-13.07-15.13-16.90-19.24

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,8981,6491,2471,3681,590798
Capital Expenditures
-550-501-498-526-548-562
Free Cash Flow
1,3481,1487498421,042236
Free Cash Flow Growth
51.46%53.27%-11.04%-19.19%341.52%-63.01%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
52.47%51.79%48.74%48.25%46.72%47.83%
Operating Margin
9.26%12.50%-1.83%2.73%-14.72%10.80%
Pretax Margin
4.09%7.09%-7.76%-3.94%-21.19%4.14%
Profit Margin
4.01%8.13%-11.85%-3.89%-16.88%2.82%
FCF Margin
7.79%6.65%4.53%5.31%6.98%1.49%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
58.1925.79---21.08
Forward PE
12.4912.078.354.213.633.02
P/FCF Ratio
30.2931.2633.3613.909.7237.45
PS Ratio
2.362.081.510.740.680.56